[1]
Mane, E., Cursano, G., Venetis, K., Frascarelli, C., Pepe, F., Nacchio, M., Palumbo, L., Pisapia, P., De Camilli, E., Castellano, I., Cerbelli, B., Costarelli, L., d’Amati, G., Rizzo, A., Santinelli, A., Scatena, C., Criscitiello, C., De Angelis, C., Dieci, M.V., Troncone, G., Curigliano, G., Viale, G., Guerini-Rocco, E., Malapelle, U. and Fusco, N. 2026. PIK3CA testing in HR+/HER2− metastatic breast cancer: assessing pathology laboratories capacity and needs. Pathologica - Journal of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology. 117, 6 (Feb. 2026). DOI:https://doi.org/10.32074/1591-951X-1603.